Cloned HTLV-1+CD4+, but not CD8+, T-cells display an oncogenic miRNome by Vernin, Céline et al.
MEETING ABSTRACT Open Access
Cloned HTLV-1+CD4+, but not CD8+, T-cells
display an oncogenic miRNome
Céline Vernin
1, Christiane Pinatel
2, Nicolas Nazaret
3, Eric Wattel
1, Catherine Legras-Lachuer
3, Franck Mortreux
1*
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium. 5-8 June 2011
HTLV-1 persistence in vivo relies on the persistent clo-
nal expansion of its host cells. These are CD4+ and
CD8+ T cells, yet ATL is regularly CD4+. Accordingly,
untransformed HTLV-1+CD4+ but not CD8+ T cells
cloned from carriers cumulate the features of preleuke-
mic cells, including multinuclearity, chromatin bridges,
increased cell cycling and inappropriate telomerase
activity. MicroRNAs (miR) modify the maturation of a
plethora of T-cells RNA and their deregulation would
therefore constitute an appropriate explanation for the
Tax-dependent or -independent pleiotropic changes in
the phenotype of HTLV-1+CD4+ T cells. As the miR-
Nome of naturally infected untransformed cells has not
been investigated to date, we assessed the miR expres-
sion profiling of T cells cloned from carriers. Microarray
results, confirmed by quantitative RTPCR, showed that,
upon infection, CD4+ and CD8+ clones yielded aberrant
expression of 15 distinct miRs including miR-34b and
miR-494 that were respectively over- and underex-
pressed in both compartments. The more prominent
effect of the infection consisted in the CD4+-restricted
overexpression of the cancer-related miRs miR-21, -27b
and -23b associated with the CD4+-restricted downre-
gulation of the proapoptotic miR-15 and -16. Data were
extended by the analysis of 40 additional CD4+ clones
(20 infected). Crossing the miRNome against the whole
transcriptome data identified putative miR-targeted
genes. In silico, those targeted by miR-23b and -27b
defined 2 hitherto unknown pathways involving the cell
cycle and genetic disorders. Therefore HTLV-1 triggers
a phenotype-specific miR signature consistent with the
preleukemic HTLV-1+CD4+ phenotype.
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